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In this issue, Pospisilik et al. (2007) demonstrate that a reduction in mitochondrial oxida-
tive phosphorylation protects mice against obesity and diabetes. This finding suggests 
that the moderate deficiency in oxidative phosphorylation that is observed in peripheral 
tissues of insulin-resistant humans is not a causative factor in diabetes but may instead be 
a compensatory response.Mitochondrial dysfunction is being 
increasingly linked to aging and the 
pathogenesis of several common dis-
eases associated with aging, includ-
ing type 2 diabetes mellitus (Krishnan 
et al., 2007). Type 2 diabetes is char-
acterized by defective insulin release 
by pancreatic β cells in response to 
glucose stimulation and decreased 
insulin sensitivity of peripheral tis-
sues. Several lines of evidence have 
implicated mitochondrial dysfunc-
tion in type 2 diabetes. In humans 
with insulin resistance, a reduction 
in the function of the mitochondrial 
respiratory chain (also known as the 
electron transport chain) has been 
observed in liver and muscle. How-
ever, it is not known whether or how 
this disruption in oxidative phospho-
rylation contributes to the pathogen-
esis of type 2 diabetes. Pospisilik 
et al. (2007) now report in this issue 
of Cell that a reduction in oxidative 
phosphorylation in the liver or muscle 
of mice does not trigger the onset of 
diabetes but instead has the opposite 
effect, protecting mice against both 
diabetes and obesity. Their finding 
suggests that the changes in respira-
tory chain function in insulin-resistant 
humans may be compensatory rather 
than causative in the pathogenesis of 
type 2 diabetes.
The pancreatic β cell depends on 
mitochondrial function to appropri-
ately control the release of insulin in 
response to variation in blood glucose 
levels (Maassen et al., 2004). Patients 
with mitochondrial disease syn-448 Cell 131, November 2, 2007 ©2007 Edromes caused by certain mutations 
in mitochondrial DNA (mtDNA) are 
often diabetic because of impaired 
insulin secretion and increased β 
cell death (Maassen et al., 2004). 
In addition, the normal aging pro-
cess in humans is associated with 
accumulation of somatic mutations 
in mtDNA and a decline in respira-
tory chain function (Krishnan et al., 
2007). Somatic mutations in mtDNA 
undergo mitotic segregation and can 
clonally expand to very high levels 
in individual cells, thereby causing a 
mosaic pattern of respiratory chain 
deficiency in tissues of older humans 
(Krishnan et al., 2007). It is possible 
that accumulation of somatic muta-
tions in mtDNA may partially explain 
the age-associated deterioration of β 
cell function and viability.
Human insulin resistance cor-
relates with reduced respiratory 
chain function in skeletal muscle, as 
determined by in vivo studies using 
magnetic resonance spectroscopy 
(Lowell and Shulman, 2005). In addi-
tion, analyses of gene expression in 
skeletal muscle of insulin-resistant 
patients show decreased expres-
sion of PGC-1α, a master regulator 
of mitochondrial biogenesis, and its 
downstream target genes (Lowell 
and Shulman, 2005). A reasonable 
interpretation of these studies is that 
inherited or age-associated acquired 
dysfunction of the respiratory chain 
in skeletal muscle may trigger insu-
lin resistance and lead to develop-
ment of type 2 diabetes. A role for lsevier Inc.mitochondria in insulin resistance 
is also supported by the fact that 
physical exercise induces mitochon-
drial biogenesis and also increases 
glucose uptake in skeletal muscle. 
Yet this hypothesis linking deficiency 
in the respiratory chain to insulin 
resistance in peripheral tissues has 
been questioned for several reasons. 
(1) Respiratory chain deficiency in 
skeletal muscle typically causes a 
compensatory increase in mitochon-
drial biogenesis driven by an activa-
tion of PGC-1α expression. Therefore, 
it is not expected that respiratory 
chain deficiency should be accompa-
nied by a decrease in mitochondrial 
biogenesis, as observed in skeletal 
muscle of insulin resistant patients. 
(2) Mice lacking PGC-1α expression 
are lean and resistant to diet-induced 
obesity (Lin et al., 2004). Unfortu-
nately, these knockout mice are also 
hyperactive, which complicates the 
interpretation of this phenotype. (3) 
A recent characterization of respi-
ratory chain function in patients 
with type 2 diabetes subjected to 
glucose/insulin infusions suggests 
that mitochondrial dysfunction is 
not an intrinsic defect but rather a 
consequence of the impaired insu-
lin response (Asmann et al., 2006). 
(4) Patients with certain mitochondrial 
disease syndromes often develop 
diabetes, as discussed above, but 
they are typically not insulin resistant 
despite having respiratory chain defi-
ciency in skeletal muscle and other 
tissues (Maassen et al., 2004).
Pospisilik and colleagues (2007) 
have tested the hypothesis that 
respiratory chain dysfunction causes 
insulin resistance by using the power 
of mouse genetics to manipulate 
expression of apoptosis-inducing 
factor (AIF). AIF is necessary for 
maintaining the normal function of 
the respiratory chain, whereas its 
role in apoptosis has been ques-
tioned (Brown et al., 2006). Tissue-
specific disruption of AIF in skeletal 
muscle or liver reduces the activity 
of complex I, the first component in 
the respiratory chain, and results in 
patterns of gene expression that are 
strikingly similar to those observed 
in skeletal muscle from insulin-resis-
tant humans. Surprisingly, animals 
with muscle-specific AIF deficiency 
(MAIFKO mice) have increased glu-
cose tolerance and increased insu-
lin sensitivity (Figure 1). They also 
have elevated expression of glucose 
transporters and display increased 
glucose uptake in skeletal muscle. 
The knockout mice have no increase 
in the production of reactive oxy-
gen species. Similarly, animals with 
liver-specific AIF deficiency (LAIFKO 
mice) show increased glucose tol-
erance. MAIFKO and LAIFKO mice 
are resistant to the development 
of obesity and diabetes when fed 
a high-fat diet (Figure 1). In other 
experiments, the authors show that 
acutely decreasing AIF expression 
or restoring AIF expression in the 
liver of LAIFKO mice can induce or 
reverse, respectively, dysfunction 
of the respiratory chain and thereby 
alter glucose homeostasis.
Does this elegant series of 
experiments exclude a role for 
mitochondrial dysfunction in caus-
ing insulin resistance? Not neces-
sarily, because AIF may have more 
than one function in mitochondria. 
Future studies are clearly needed 
to address the molecular mecha-
nisms by which AIF interacts with 
the respiratory chain. However, the 
conclusions of Pospisilik and col-
leagues (2007) are supported by 
the finding that deletion of the gene 
encoding mitochondrial transcrip-
tion factor A (Tfam) in mouse skele-
tal muscle causes a global progres-Figure 1. Decreased AIF Expression Protects against Diabetes and obesity
Studies using global gene expression and in vivo magnetic resonance spectroscopy suggest that 
respiratory chain deficiency in the mitochondria of skeletal muscle may cause insulin resistance 
in humans. Muscle- or liver-specific inactivation of apoptosis-inducing factor (AIF) results in a 
respiratory chain deficiency that primarily affects complex I. The mutant mice have patterns of 
gene expression closely resembling those seen in patients with insulin resistance and type 2 
diabetes mellitus. Unexpectedly, mice deficient in AIF are leaner than littermate controls and 
show improved glucose tolerance and increased insulin sensitivity in peripheral tissues. In addi-
tion, AIF-deficient mice are resistant to developing obesity and diabetes when fed a high-fat diet. 
These findings show that reduced respiratory chain function can counteract the development of 
diabetes and obesity.sive deficiency of the respiratory 
chain, a lowering of blood glucose 
levels, and an increase in peripheral 
glucose uptake (Wredenberg et al., 
2006). Similarly, mtDNA-mutator 
mice, which exhibit a widespread 
tissue distribution of respiratory 
chain deficiency because of accu-
mulation of somatic point mutations 
in mtDNA, are lean and have lower 
blood glucose levels than control 
animals (Trifunovic et al., 2004; N.-
G.L., unpublished data).
Intriguingly, the study by Pospisilik 
et al. (2007) indicates that moderate 
dysfunction in the respiratory chain 
may have beneficial metabolic effects. 
It has previously been reported that 
activation of the deacetylase SIRT1 
by resveratrol leads to deacetylation 
of PGC-1α, which in turn is activated 
to increase mitochondrial biogen-
esis (Lagouge et al., 2006). Animals 
treated with resveratrol are protected Cell 131, Noagainst diet-induced obesity, which 
may be explained by enhanced mito-
chondrial biogenesis (Lagouge et al., 
2006). However, it should be empha-
sized that resveratrol has pleiotropic 
pharmacological effects and that 
other mechanisms, in addition to acti-
vation of mitochondrial biogenesis, 
may be important. Thus, there are 
published data suggesting that both 
moderate increases and moderate 
decreases in respiratory chain func-
tion have advantageous effects. It will 
be interesting to unravel the molecu-
lar mechanisms behind this dualism 
and to determine whether the benefi-
cial effects of a moderate reduction 
in mitochondrial function prolong life 
span in mice.
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The ribosome is often considered a 
rather monochromatic machine that 
has persisted more or less unchanged 
for the past three billion years. That 
picture has begun to take on color as 
we see the intricate structure of the 
ribosomal RNAs with their associ-
ated proteins and as we learn of the 
subtle differences between eubacte-
rial, archaeal, eukaryotic, and organ-
ellar ribosomes. New work by Komili 
et al. (2007) presented in this issue 
suggests that the ribosome, at least 
in yeast, has far more versatility than 
anyone had imagined.
About one hundred million years 
ago, there occurred duplication of the 
genome of an S. cerevisiae ancestor 
(Wolfe and Shields, 1997). Although 
most of the duplicate genes were 
either lost or evolved new functions, 
fifty-nine pairs of paralogous genes 
that encode identical or very similar 
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ribosomal proteins were retained. 
It has been thought that this served 
to accommodate the yeast cell’s 
extraordinary need for ribosomal 
proteins (Warner, 1999). Although 
this may be part of the reason why 
so many ribosomal protein paralogs 
were retained in S. cerevisiae, Komili 
et al. now provide several lines of evi-
dence to suggest that only rarely are 
individual members of a paralogous 
gene pair functionally identical. The 
authors have built on the observa-
tion that in some cases deletion of 
only one gene of a paralogous pair 
alters bud site selection in S. cer-
evisiae (Ni and Snyder, 2001). Taking 
advantage of the well-studied local-
ization of ASH1 mRNA to the bud tip 
(Darzacq et al., 2003), they examined 
ASH1 mRNA localization after dele-
tion of many of the paralogous genes 
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Commun. 350, 202–207.subunits. The authors find clear dif-
ferences in the localization of ASH1 
mRNA, which appear to correlate with 
bud site selection. These effects are 
neither dependent on the expression 
level of the duplicate genes nor are 
they suppressed by overexpression 
of the other gene, suggesting that the 
paralogous proteins are performing 
different functions.
The authors extended their primary 
observations by exploiting the tools 
of systems biology in two powerful 
ways. First, they compared the tran-
scriptomes of yeast cells in which par-
alogs of genes encoding ribosomal 
proteins have been deleted and found 
substantial differences. Then, they 
mined a variety of data sets describ-
ing the phenotypic effects of paralog 
deletion, and they report marked vari-
ance between paralogs. From these 
data, the authors infer that the paral-
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e not functionally equivalent, 
